The nuclear xenobiotic receptor CAR: Structural determinants of constitutive activation and heterodimerization

Molecular Cell

Volumn 16, Issue 6, 2004, Pages 893-905

  Suino, Kelly ^a   Peng, Li ^b   Reynolds, Ross ^a   Li, Yong ^a   Cha, Ji Young ^b   Repa, Joyce J ^b   Kliewer, Steven A ^b   Xu, H Eric ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CONSTITUTIVE ANDROSTANE RECEPTOR; RETINOID X RECEPTOR; THYROID HORMONE; XENOBIOTIC AGENT;

ARTICLE; DIMERIZATION; HORMONE METABOLISM; LIGAND BINDING; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; ANIMALS; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOID X RECEPTOR ALPHA; TRANSCRIPTION FACTORS;

EID: 10944250224     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2004.11.036     Document Type: Article

References (56)

1. Baes M., Gulick T., Choi H.S., Martinoli M.G., Simha D., Moore D.D. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell. Biol. 14:1994;1544-1552
2. Barroso I., Gurnell M., Crowley V.E., Agostini M., Schwabe J.W., Soos M.A., Maslen G.L., Williams T.D., Lewis H., Schafer A.J., et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature. 402:1999;880-883
3. Bledsoe R.K., Montana V.G., Stanley T.B., Delves C.J., Apolito C.J., McKee D.D., Consler T.G., Parks D.J., Stewart E.L., Willson T.M., et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell. 110:2002;93-105
4. Bourguet W., Vivat V., Wurtz J.M., Chambon P., Gronemeyer H., Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell. 5:2000;289-298
5. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921
6. Choi H.S., Chung M., Tzameli I., Simha D., Lee Y.K., Seol W., Moore D.D. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J. Biol. Chem. 272:1997;23565-23571
7. Connolly M.L. Solvent-accessible surfaces of proteins and nucleic acids. Science. 221:1983;709-713
8. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., Fletterick R.J., Yamamoto K.R. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12:1998;3343-3356
9. Dhe-Paganon S., Duda K., Iwamoto M., Chi Y.I., Shoelson S.E. Crystal structure of the HNF4alpha ligand binding domain in complex with endogenous fatty acid ligand. J. Biol. Chem. 277:2002;37973-37976. Published online August 21, 2002
10. Dussault I., Lin M., Hollister K., Fan M., Termini J., Sherman M.A., Forman B.M. A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity. Mol. Cell. Biol. 22:2002;5270-5280
11. Forman B.M., Tzameli I., Choi H.S., Chen J., Simha D., Seol W., Evans R.M., Moore D.D. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature. 395:1998;612-615
12. Frank C., Molnar F., Matilainen M., Lempiainen H., Carlberg C. Agonist-dependent and agonist-independent transactivation of the human constitutive androstane receptor are modulated by specific amino acid pairs. J. Biol. Chem. 279:2004;33558-33566. Published online May 19, 2004
13. Gampe R.T. Jr., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K., Milburn M.V., Kliewer S.A., Willson T.M., Xu H.E. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell. 5:2000;545-555
14. Greschik H., Wurtz J.M., Sanglier S., Bourguet W., van Dorsselaer A., Moras D., Renaud J.P. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol. Cell. 9:2002;303-313
15. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736
16. Honkakoski P., Zelko I., Sueyoshi T., Negishi M. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital- responsive enhancer module of the CYP2B gene. Mol. Cell. Biol. 18:1998;5652-5658
17. Honkakoski P., Sueyoshi T., Negishi M. Drug-activated nuclear receptors CAR and PXR. Ann. Med. 35:2003;172-182
18. Hu X., Lazar M.A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature. 402:1999;93-96
19. Huang W., Zhang J., Chua S.S., Qatanani M., Han Y., Granata R., Moore D.D. Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. USA. 100:2003;4156-4161
20. Jyrkkarinne J., Makinen J., Gynther J., Savolainen H., Poso A., Honkakoski P. Molecular determinants of steroid inhibition for the mouse constitutive androstane receptor. J. Med. Chem. 46:2003;4687-4695
21. Kawamoto T., Sueyoshi T., Zelko I., Moore R., Washburn K., Negishi M. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell. Biol. 19:1999;6318-6322
22. Kleywegt G.J., Jones T.A. Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr. D Biol. Crystallogr. 50:1994;178-185
23. Kliewer S.A., Moore J.T., Wade L., Staudinger J.L., Watson M.A., Jones S.A., McKee D.D., Oliver B.B., Willson T.M., Zetterstrom R.H., et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 92:1998;73-82
24. Kliewer S.A., Xu H.E., Lambert M.H., Willson T.M. Peroxisome proliferator-activated receptors. from genes to physiology Recent Prog. Horm. Res. 56:2001;239-263
25. Li Y., Lambert M.H., Xu H.E. Activation of nuclear receptors. a perspective from structural genomics Structure (Camb). 11:2003;741-746
26. Maglich J.M., Watson J., McMillen P.J., Goodwin B., Willson T.M., Moore J.T. The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J. Biol. Chem. 279:2004;19832-19838
27. Moore L.B., Goodwin B., Jones S.A., Wisely G.B., Serabjit-Singh C.J., Willson T.M., Collins J.L., Kliewer S.A. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. USA. 97:2000;7500-7502. a
28. Moore L.B., Parks D.J., Jones S.A., Bledsoe R.K., Consler T.G., Stimmel J.B., Goodwin B., Liddle C., Blanchard S.G., Willson T.M., et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 275:2000;15122-15127. b
29. Nagy L., Kao H.Y., Love J.D., Li C., Banayo E., Gooch J.T., Krishna V., Chatterjee K., Evans R.M., Schwabe J.W. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 13:1999;3209-3216
30. Navaza J., Gover S., Wolf W. AMoRe. a new package for molecular replacement Dodson E.J. Molecular Replacement. Proceedings of the CCP4 Study Weekend:1992;87-90 SERC, Daresbury, UK
31. Nettles K.W., Sun J., Radek J.T., Sheng S., Rodriguez A.L., Katzenellenbogen J.A., Katzenellenbogen B.S., Greene G.L. Allosteric control of ligand selectivity between estrogen receptors alpha and beta. implications for other nuclear receptors Mol. Cell. 13:2004;317-327
32. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., Milburn M.V. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature. 395:1998;137-143
33. Otwinowski Z., Minor W. Processing of x-ray diffraction data collected in oscillation mode. Carter J.C.W., Sweet R.M. Macromolecular Crystallography. 1997;307-326 Academic Press, New York
34. Perissi V., Staszewski L.M., McInerney E.M., Kurokawa R., Krones A., Rose D.W., Lambert M.H., Milburn M.V., Glass C.K., Rosenfeld M.G. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13:1999;3198-3208
35. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell. 5:2000;173-179
36. Sablin E.P., Krylova I.N., Fletterick R.J., Ingraham H.A. Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. Mol. Cell. 11:2003;1575-1585
37. Shan L., Vincent J., Brunzelle J.S., Dussault I., Lin M., Ianculescu I., Sherman M.A., Forman B.M., Fernandez E.J. Structure of the murine constitutive androstane receptor complexed to androstenol. a molecular basis for inverse agonism Mol. Cell. 16:2004;907-917., this issue
38. Sheppard K.A., Phelps K.M., Williams A.J., Thanos D., Glass C.K., Rosenfeld M.G., Gerritsen M.E., Collins T. Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J. Biol. Chem. 273:1998;29291-29294
39. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 95:1998;927-937
40. Shulman A.I., Larson C., Mangelsdorf D.J., Ranganathan R. Structural determinants of allosteric ligand activation in RXR heterodimers. Cell. 116:2004;417-429
41. Sonoda J., Rosenfeld J.M., Xu L., Evans R.M., Xie W. A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection. Curr. Drug Metab. 4:2003;59-72
42. Stanley T.B., Leesnitzer L.M., Montana V.G., Galardi C.M., Lambert M.H., Holt J.A., Xu H.E., Moore L.B., Blanchard S.G., Stimmel J.B. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity. Biochemistry. 42:2003;9278-9287
43. Sueyoshi T., Kawamoto T., Zelko I., Honkakoski P., Negishi M. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. 274:1999;6043-6046
44. Svensson S., Ostberg T., Jacobsson M., Norstrom C., Stefansson K., Hallen D., Johansson I.C., Zachrisson K., Ogg D., Jendeberg L. Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation. EMBO J. 22:2003;4625-4633
45. Synold T.W., Dussault I., Forman B.M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med. 7:2001;584-590
46. Tzameli I., Pissios P., Schuetz E.G., Moore D.D. The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol. Cell. Biol. 20:2000;2951-2958
47. Ueda A., Kakizaki S., Negishi M., Sueyoshi T. Residue threonine 350 confers steroid hormone responsiveness to the mouse nuclear orphan receptor CAR. Mol. Pharmacol. 61:2002;1284-1288
48. Watkins R.E., Wisely G.B., Moore L.B., Collins J.L., Lambert M.H., Williams S.P., Willson T.M., Kliewer S.A., Redinbo M.R. The human nuclear xenobiotic receptor PXR. structural determinants of directed promiscuity Science. 292:2001;2329-2333
49. Wei P., Zhang J., Egan-Hafley M., Liang S., Moore D.D. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature. 407:2000;920-923
50. Wei P., Zhang J., Dowhan D.H., Han Y., Moore D.D. Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J. 2:2002;117-126
51. Willson T.M., Kliewer S.A. PXR, CAR and drug metabolism. Nat. Rev. Drug Discov. 1:2002;259-266
52. Xie W., Barwick J.L., Simon C.M., Pierce A.M., Safe S., Blumberg B., Guzelian P.S., Evans R.M. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev. 14:2000;3014-3023
53. Xu H.E., Stanley T.B., Montana V.G., Lambert M.H., Shearer B.G., Cobb J.E., McKee D.D., Galardi C.M., Plunket K.D., Nolte R.T., et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature. 415:2002;813-817
54. Xu R.X., Lambert M.H., Wisely B.B., Warren E.N., Weinert E.E., Waitt G.M., Williams J.D., Collins J.L., Moore L.B., Willson T.M., et al. A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol. Cell. 16:2004;919-928., this issue
55. Yoshinari K., Kobayashi K., Moore R., Kawamoto T., Negishi M. Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett. 548:2003;17-20
56. Zhang J., Huang W., Chua S.S., Wei P., Moore D.D. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science. 298:2002;422-424